| You are here: Home: BCU 9|2003 - Supplement : Case 1: From the practice of Stephanie Bernik, MD: Select publications
Select publications
Clinical trials of adjuvant trastuzumab
Early Breast Cancer Trialists' Collaborative Group. Adjuvant endocrine therapy in premenopausal women ovarian ablation for early breast cancer. Cochrane Database Syst Rev 2000;CD000485. No abstract available.
Davidson N et al. Effect of chemohormonal therapy in premenopausal, node (+), receptor (+) breast cancer: An Eastern Cooperative Oncology Group Phase III Intergroup trial (E5188, INT-0101). Proc ASCO 1999; Abstract 249A, 67A.
Gnant M et al. Changes in bone mineral density caused by anastrozole or tamoxifen in combination with goserelin (± zoledronate) as adjuvant treatment for hormone receptor-positive premenopausal breast cancer: Results of a randomized multicenter trial. Breast Cancer Res Treat 2002;Abstract 12.
Michaud LB, Buzdar AU. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer. Drugs Aging 2000;16:261-71. Abstract
Seidman A et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002;20(5):1215-21. Abstract
Slamon DJ et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344(11):783-92. Abstract
|
